Amended Current Report Filing (8-k/a)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

---

Form 8-K /A

(Amendment No. 1) 

---

CURRENT REPORT  

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

Date of report (Date of earliest event reported): January 6 , 201 7

---

Vermillion, Inc.

(Exact Name of Registrant as Specified in Charter)

---



Delaware	001-34810	33-0595156
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)



12117 Bee Caves Road , Building Three, Suite 100, Austin, TX 78738  

(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code:  [phone]

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 

---

 

Explanatory Note

This Amendment No. 1 to Form 8-K (this “Form 8-K/A”) is an amendment to the Current Report on Form 8-K, originally filed by Vermillion, Inc. with the Securities and Exchange Commission on January 6, 2017 (the “Original Report”). Vermillion, Inc. is filing this Form 8-K/A solely to correct the date of report indicated on the cover page of the Original Report and on the signature page of the Original Report.





Item 7.01.  Regulation FD Disclosure.

A copy of the investor presentation that Vermillion, Inc. plans to use in conjunction with meetings, beginning on January 9 ,   2017 , during the J.P. Morgan Healthcare Conference is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. 





---



Item 9.01 Financial Statements and Exhibits.



(d)         Exhibit No. Description.

99.1 Vermillion, Inc. investor presentation dated January 9, 201 7

---

---

 

 

---

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	Vermillion, Inc.
Date: January  6 ,   2017	By: /s/ Eric J. Schoen
	Name: Eric J. Schoen
	Title: Senior Vice President, Finance and  Chief Accounting Officer



 



---

 

EXHIBITS INDEX

Exhibit No. Description

99.1 Vermillion, Inc. investor presentation dated January 201 7







---